Biopharmaceuticals
Oncology
Licensing
News Release - November 2, 2016
Verastem Licenses Duvelisib from Infinity Pharmaceuticals
Source: Verastem
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.